Procter & Gamble Health Limited

NSE PGHL.NS

Procter & Gamble Health Limited Return on Assets (ROA) for the year ending June 30, 2024: 25.30%

Procter & Gamble Health Limited Return on Assets (ROA) is 25.30% for the year ending June 30, 2024, a 21.41% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Procter & Gamble Health Limited Return on Assets (ROA) for the year ending June 30, 2023 was 20.84%, a -3.26% change year over year.
Procter & Gamble Health Limited Return on Assets (ROA) for the year ending June 30, 2022 was 21.54%, a 20.15% change year over year.
Procter & Gamble Health Limited Return on Assets (ROA) for the year ending June 30, 2021 was 17.93%, a 24.51% change year over year.
Procter & Gamble Health Limited Return on Assets (ROA) for the year ending June 30, 2020 was 14.40%, a -69.79% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

NSE: PGHL.NS

Procter & Gamble Health Limited

CEO	Mr. Milind Vasant Thatte M.B.A.
IPO Date	July 1, 2002
Location	India
Headquarters	Godrej One
Employees	1,407
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Key trends

Past 5 years